Major progress achieved in clinical development and strong cash position
announces positive outcomes of biomarker study measuring intracellular GAGs in leukocytes from MPS VI patients
Financial Information and Business Update
To present in vivo data with odiparcil at the 14th WORLDSymposium™
Inventiva Announces Positive DSMB Review in Phase IIb FASST Trial in Systemic Sclerosis with Lanifibranor
ANNOUNCES ENROLLMENT OF FIRST PATIENT INTO ITS ODIPARCIL PHASE IIA TRIAL (IMPROVES) FOR MPS VI
Lanifibranor: Phase IIb trial in NASH, recruiting now
Lanifibranor: Phase IIb trial in Systemic Sclerosis.
Odiparcil: Phase IIa in MPSVI, recruiting now
No front page content has been created yet.